Leadership
The Intelligent Bio Solutions management team, scientific team and board of Directors have significant global experience in the development of pharmaceuticals, medical devices and product launches.
Leadership Team
Harry Simeonidis
President & CEO
With more than 25 years in healthcare, pharmaceutical and life sciences, Harry has held various senior management positions across Asia Pacific. Before joining Intelligent Bio Solutions, he was the General Manager, Surgery, Asia Pacific, at GE Healthcare where led significant market expansion. Prior to this, Harry served as President and CEO of GE Healthcare ANZ for nine years.
Spiro Sakiris
Chief Financial Officer
Spiro is a seasoned finance professional with over 35 years of expertise in accounting, taxation, Initial Public Offerings (IPOs), capital raising, and business system designs. His work spans International Financial Reporting Standards (IFRS) and US Generally Accepted Accounting Principles (GAAP) frameworks within the life science sector. He is a member of the Institute of Chartered Accountants of Australia & New Zealand.
Doug Heath
Vice President of Global Sales
Doug is a senior sales professional with over a decade of experience leading commercial strategies across global markets. Earlier in his career, Doug contributed to several large-scale infrastructure projects in the Middle East, including the Burj Khalifa and Lusail Village for the Qatari FIFA World Cup. As Vice President of Global Sales, Doug has been instrumental in driving sales and expanding Intelligent Bio Solutions’ market presence.
Peter Passaris
Vice President of Product Development
Peter has over 20 years of experience in the industrial energy and life science sectors, with a background in chemical engineering and leadership roles across North America and Australia. Before joining Intelligent Bio Solutions, he served as Area Manager for Ecolab’s oil and gas division on the West Coast of North America, specializing in process and water applications and acting as a subject matter expert across multiple disciplines.
Anna Turkington
Vice President of Marketing
Anna is a senior marketing and communications specialist with over ten years of experience in corporate, non-profit, and agency environments. She leads the development and execution of integrated marketing strategies with a results-oriented approach. Anna also contributes to the business community through advisory and volunteer work, offering guidance on marketing fundamentals.
Rafael Da Luz
Vice President of Regulatory Affairs
Rafael has over 20 years of experience in the medical device and pharmaceutical industries. He holds a business degree from San Diego State University and an Master of Business Administration (MBA) from Durham University. He previously held regulatory and quality roles at Bayer and ResMed, managing global registrations FDA clearance, CE marking, and regulatory processes across Latin America and Africa.
Callistus Sequeira
Vice President of Global Quality & Operations
Callistus brings over 20 years of experience in manufacturing, operations, and procurement. He holds a Bachelor of Engineering, Master of Arts in International Business, and a postgraduate qualification from the Chartered Institute of Marketing. As a Lean Six Sigma Black Belt, he leads the manufacturing and quality assurance teams and ensures compliance with ISO 9001 and ISO 13485 standards.
Ghanshyam Poudel
Finance Director
Ghanshyam is a senior finance executive with over ten years of experience in ASX and NASDAQ-listed companies. He has been instrumental in IPO readiness, including serving as the finance lead for a US$29 million NASDAQ listing. His expertise lies in financial reporting, regulatory compliance, and stakeholder engagement, with a proven ability to design scalable processes and advise on strategic planning and business performance.
Board of Directors
Dr. Steven Boyages M.D., MB, BS, Ph.D
Chairman of the Board
Steven is a practicing endocrinologist with more than 30 years’ experience in medicine, including multiple executive positions. He previously held the position of Chief Executive of the Sydney West Area Health Service (SWAHS), now known as Western Sydney Local Health District (WSLHD). Steven also served as Medical Director for eHealth New South Wales, and was the foundation Chief Executive of the Clinical Education and Training Institute (CETI), now the Health Education and Training Institute (HETI).
Previous to this, Steven was the Director of Diabetes and Endocrinology at Westmead Hospital. During this time, his major achievements were to define the pathophysiology of thyroid hormone deficiency on brain development secondary to iodine deficiency; to develop prevention strategies in iodine deficient communities in China, India, Indonesia and Northern Italy; to define the impact of growth hormone excess and deficiency in adults and to develop innovative population health models of care for people with diabetes. Steven continues an active research career in the pursuit of better models of chronic disease prevention and management.
In 1999, Steven became the founding director of the Centre for Research and Clinical Policy at NSW Health, where he launched the Priority Health Programs, expanded research funding, established the Quality Branch, and advised on the Government Action Plan for Health Reform. He also helped create and secure $150 million (AUD) in funding for the NSW BioFirst biotechnology strategy.
Nicola Fraser
Chair, Audit Committee (Independent)
Nicola is currently the Managing Partner of NextKey Services LLC, a financial consulting company she co-founded in 2019 that advises high-growth companies on strategic financial matters. From 2015 to 2018, prior to founding NextKey, Nicola served as Executive Director – Finance, Regulatory Capital at JP Morgan Chase. While at JP Morgan Chase and in her previous senior executive positions at Fannie Mae and Deloitte, she led significant financial transformations and regulatory compliance initiatives. Nicola is an active Certified Practising Accountant (CPA), licensed in Texas, and holds an American Institute of Certified Public Accountants (AICPA) Chartered Global Management Accountant (CGMA) designation.
Jason Isenberg
Director (Independent)
Jason currently serves as Assistant General Counsel for RFA Management Company, LLC in Atlanta, Georgia, where he advises a large, endowment-style portfolio in matters including corporate governance, corporate and real estate transactions, business operations, employment law and risk mitigation. Jason successfully negotiated strategic transactions exceeding $500,000,000. He obtained his Bachelor of Arts from the University of Maryland and his Juris Doctor from New England Law in Boston.
Jonathan Hurd CAMS
Director (Independent)
Johnathon has served on the Intelligent Bio Solutions Board of Directors since April 2018 and was Chairman of the Board from August 2018 to November 2019. He brings deep expertise in broker-dealer and investment advisory regulations, with extensive knowledge of FINRA and U.S. Securities and Exchange Commission (SEC) rules. Since founding Asgard Regulatory Group in 2008, he has served as its CEO. Earlier in his career, Johnathon was Supervisor of Examiners at FINRA (formerly NASD) in the New York District Office, where he oversaw firm examinations and led enforcement cases in collaboration with the U.S. Department of Justice and the FBI. He is a Certified Anti-Money Laundering Specialist (CAMS) and holds multiple licenses, including Series 7, 24, 27, 53, 55, 63, 66, 79, 99, and NYS Life and Health Insurance.